Research Analysts Set Expectations for EW Q3 Earnings
Edwards Lifesciences Co. (NYSE:EW – Free Report) – Equities research analysts at Leerink Partnrs raised their Q3 2025 earnings estimates for shares of Edwards Lifesciences in a report issued on Thursday, May 29th. Leerink Partnrs analyst M. Kratky now expects that the medical research company will post earnings per share of $0.61 for the quarter, […]
